VASTHERA Co.Ltd.
- Biotech or pharma, therapeutic R&D
VASTHERA Co., Ltd. is a Korea-based pre-clinical stage pharmaceutical company pioneering first-in-class small molecule drugs for chronic inflammatory diseases, such as cardiovascular, cancer, eye, and neurodegenerative diseases, through innovative platforms, 'Redoxizyme' and 'ATGen,' which generate small molecules that target redox and autophagy (ATG) signaling pathways critical for the onset and pathogenesis of these diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}